Related content

The role of generics in transplantation

By Masri M.A.   Andrysek T.   Matha V.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2745-2747

Elsevier

Access to resources Recommend Favorite

CSA/MMF/steroids versus CSA/AZA/steroids with and without basiliximab in cadaveric kidney transplantation

By Boggi U.   Vistoli F.   Del Chiaro M.   Bartolo T.V.   Rizzo G.   Mosca F.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3199-3200

Elsevier

Access to resources Recommend Favorite

Mycophenolate Mofetil (Cellcept) in Renal Transplantation: The European Experience

By European Mycophenolate Mofetil Co-operative Study Group   Garl S.   Wiesel M.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2932-2935

Elsevier

Access to resources Recommend Favorite

Cellcept enhances the rate of apoptosis in T cells after renal transplantation

By Kasprzycka M.   Wierzbicki P.   Nowaczyk M.   Gorski A.   Serafinowicz A.   Durlik M.   Wyzgal J.   Korczak-Kowalska G.   Gradowska L.   Chmura A.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 328-328

Elsevier

Access to resources Recommend Favorite

First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV

By Langrehr J.M.   Neumann U.P.   Lang M.   Muller A.R.   Jonas S.   Settmacher U.   Steinmuller T.   Neuhaus P.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1565-1566

Elsevier

Access to resources Recommend Favorite